BMRN FY 2020 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena

BMRNBioMarin Pharmaceutical Inc.

$12B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.9B+9.2% YoY

Gross Profit

$1.3B71.8% margin

Operating Income

-$43M-2.3% margin

Net Income

$854M45.9% margin

EPS (Diluted)

$4.53

Cash Flow

Operating Cash Flow

$85M

Free Cash Flow

-$52M

Stock-Based Comp.

$190M

Balance Sheet

Total Assets

$5.8B

Total Liabilities

$1.7B

Stockholders' Equity

$4.1B

Cash & Equivalents

$649M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.9B	$1.7B	+9.2%
Gross Profit	$1.3B	$1.3B	-0.6%
Operating Income	-$43M	-$100M	+56.8%
Net Income	$854M	-$24M	+3681.1%